Firms

Amplitude Ventures

Montreal · Toronto · Calgary

Amplitude Ventures is a Canadian life-sciences venture investor and biotechnology company builder focused on precision medicine at the intersection of biology and AI. It backs therapeutic platforms, drug-discovery technologies and companies developing treatments matched to disease mechanisms and patient biology. Its published focus includes neurology and neurovascular disease, cancer, immunology and inflammation, metabolic disorders and rare diseases. Through its internal Pre-Amp venture studio, the firm develops scientific hypotheses, incubates technologies and helps assemble new biotechnology companies. It also supports existing companies with financing, business development and scientific strategy.

Founded: 2018
Type: Venture capital

Funds1

Amplitude Ventures Fund II2024-05-282024-05-28CA$263M
Amplitude Ventures’ second precision-medicine venture fund finances and helps build biotechnology companies using advances in biology and AI to discover and develop new treatments. Its first four disclosed investments were Evommune, Tentarix Biotherapeutics, Reverb Therapeutics and Evolved Therapeutics.

Team

Operations and support

Ali TehraniEntrepreneur in Residence

Allison GawPartner

Bharat SrinivasaPartner

Colton StrongAnalyst

Dion MadsenManaging Partner

Evelyn PauPrincipal

Jean-François PariseauManaging Partner

Juliana Muñoz EscobarAssociate

Karen N. LiManager, Marketing and Communications

Matthew RosenbergerPartner, CFO

Michael MeePartner

Nadia LachmanInvestor

Nancy HarrisonVenture Partner

Riccardo CardilliFinance Director

Investments

team@apexlogos.ai21 hours ago
All14 current own published roles included. Michael Mee is also Managing Director of the internal Pre-Amp studio, retained in biography rather than creating a separate manager or duplicating fund ownership. Current April2026 promotion titles supersede 2024 release titles. Own co-founder biographies say founded2018, while the 2024 release describes supporting entrepreneurs since2019; these are distinct founding/public-operation milestones. Current own contact lists Montreal, Toronto and Calgary, superseding 2024 historical Vancouver office wording. Portfolio partnership years are years only, not round announcement dates. Historical fellowship testimonials/cohorts are not asserted to be current employees. Native software companies Amplitude and Amplitude Inc remain separate. Source: https://amplitudevc.com/en/people ; https://amplitudevc.com/en/news/promotions-reinforce-amplitudes-senior-leadership-as-the-firm-scales-its-venture-platform-in-precision-medicine-and-company-creation ; https://www.newswire.ca/news-releases/amplitude-ventures-closes-263-million-precision-medicine-venture-fund-862315181.html ; https://amplitudevc.com/en/contact

$—2026-04-30	RIME Therapeutics	Amplitude Ventures
$39M2026-03-19	Congruence Therapeutics	Amplitude Ventures
$32M2025-09-04	Congruence Therapeutics	Amplitude Ventures
$27M2024-12-16	Fluid Biomed	Amplitude Ventures, METIS Innovative, ShangBay Capital, IAG Capital Partners, LifeArc Ventures
$42M2024-09-17	Nomic Bio	Y Combinator, Real Ventures, Lux Capital, SR One, Amplitude Ventures
$—2023-03-06	Congruence Therapeutics	Investissement Québec, Amplitude Ventures
CA$9M2022-04-11	DrugBank	Milad Alucozai, Amplitude Ventures, Theodorus IV
$50M2022-02-08	Congruence Therapeutics	Amplitude Ventures
$40M2022-01-31	Gandeeva Therapeutics	Lux Capital, Amplitude Ventures
$7M2021-12-15	Valence Discovery	Fifty Years, Seth Bannon, Nathan Benaich, Amplitude Ventures
$43M2021-11-03	Prilenia Therapeutics	Morningside Ventures, Amplitude Ventures, ALS Investment Fund
$180M2021-07-28	Deep Genomics	Deep Nishar, Elena Viboch, Amplitude Ventures
$40M2020-01-07	Deep Genomics	Future Ventures, Vinod Khosla, Amplitude Ventures
$700K2025-11-12	Spiich Labs	Creandum, OpenAI Startup Fund, Lovable, Amplitude Ventures, Mandeep Singh

Funds1

Team

Operations and support

Co-investing

Investments